de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .
No injuries were reported after a dryer caught on fire in a home on Madison's East side Tuesday night. Firefighters were dispatched to a residence on Open Wood Way at 7:17 p.m., where they noted a ...
When I lost weight on WW, I devoted all of my time to the program and I was successful. It was when life got hard that the food noise returned. So, my doctor and I decided to try Zepbound (tirzepatide ...
The group lost an average of 8.6% of their body weight over 16 weeks. Patients on a higher dose of the drug experienced similar weight loss, but with more side effects, Zealand said. A number of ...
The group lost an average of 8.6% of their body weight over 16 weeks. Patients on a higher dose of the drug experienced similar weight loss, but with more side effects, Zealand said.
Additionally, suzetrigine’s lack of central nervous system-specific side effects, which are common with other treatments like pregabalin, adds to its appeal. The Phase 2 trial’s robust design ...
AstraZeneca said its experimental weight loss pill was well tolerated by patients in an early-stage clinical trial. The Anglo-Swedish drugmaker’s closely watched weight loss pill, AZD5004 ...
The trial of the once-daily drug--which mimics a gut hormone known as GLP-1 to control blood sugar and suppress appetite--showed no severe side effects among patients with dosages of up to 50mg.